CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- 4 Grant or award Executive Chairman acquired 9,012 shares (grant or award)
- 4 Grant or award CEO & President acquired 38,857 shares (grant or award)
- 4 Grant or award EVP and CMO acquired 11,333 shares (grant or award)
- 4 Grant or award EVP and Chief Legal Officer acquired 9,068 shares (grant or award)
- 4 Grant or award EVP, Chief Technical Ops. Off. acquired 7,817 shares (grant or award)
- 4 Grant or award SVP & Chief Accounting Officer acquired 4,250 shares (grant or award)
- 4 Grant or award EVP, Chief Scientific Officer acquired 11,194 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale EVP, Chief Reg. & Quality Off. sold 4,500 shares at $474.99 ($2,137,455)
- 4 Planned sale EVP, CO & FO sold 9,532 shares at $461.00 ($4,394,252)
- 4 Planned sale EVP, CO & FO sold 14,000 shares at an average $456.00 ($6,384,000)
- 4 Planned sale EVP, Chief Reg. & Quality Off. sold 4,500 shares at $449.99 ($2,024,955)
- 4 Planned sale Executive Chairman sold 63,781 shares at an average $449.20 ($28,650,337)
- 4 Planned sale EVP and Chief Legal Officer sold 347 shares at $449.00 ($155,803)
- 4 Gift Director gave 800 shares (gift)
- 4 Planned sale EVP, Chief Technical Ops. Off. sold 2,500 shares at $434.58 ($1,086,450)
- 4 Planned sale Executive Chairman sold 73,292 shares at an average $440.60 ($32,292,320)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 129 · 2,568 filings